Chronic myeloid leukemia (CML) is a malignant proliferative disease originated from a fusion gene bcr-abl, which is produced by the translocation of the abl1 gene in chromosome 9 and the bcr gene in chromosome 22 (1–3). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.